ID   PTGIS_HUMAN             Reviewed;         500 AA.
AC   Q16647; Q3MII8; Q9HAX2; Q9HAX3; Q9HAX4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 169.
DE   RecName: Full=Prostacyclin synthase;
DE            EC=5.3.99.4 {ECO:0000269|PubMed:25623425};
DE   AltName: Full=Prostaglandin I2 synthase;
GN   Name=PTGIS; Synonyms=CYP8, CYP8A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Aorta;
RX   PubMed=8185632; DOI=10.1006/bbrc.1994.1652;
RA   Miyata A., Hara S., Yokoyama C., Inoue H., Ullrich V., Tanabe T.;
RT   "Molecular cloning and expression of human prostacyclin synthase.";
RL   Biochem. Biophys. Res. Commun. 200:1728-1734(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LEU-38; ARG-118 AND SER-379.
RX   PubMed=11281454; DOI=10.1007/s004390000444;
RA   Chevalier D., Cauffiez C., Bernard C., Lo-Guidice J.-M., Allorge D.,
RA   Fazio F., Ferrari N., Libersa C., Lhermitte M., D'Halluin J.C.,
RA   Broly F.;
RT   "Characterization of new mutations in the coding sequence and 5'-
RT   untranslated region of the human prostacyclin synthase gene
RT   (CYP8A1).";
RL   Hum. Genet. 108:148-155(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN EHT.
RX   PubMed=12372404; DOI=10.1016/S0006-291X(02)02341-0;
RA   Nakayama T., Soma M., Watanabe Y., Hasimu B., Sato M., Aoi N.,
RA   Kosuge K., Kanmatsuse K., Kokubun S., Marrow J.D., Oates J.A.;
RT   "Splicing mutation of the prostacyclin synthase gene in a family
RT   associated with hypertension.";
RL   Biochem. Biophys. Res. Commun. 297:1135-1139(2002).
RN   [6]
RP   BIOPHYSICOCHEMICAL PROPERTIES, VARIANT THR-447, CHARACTERIZATION OF
RP   VARIANT THR-447, AND CATALYTIC ACTIVITY.
RX   PubMed=25623425; DOI=10.1016/j.abb.2015.01.012;
RA   Cho S.A., Rohn-Glowacki K.J., Jarrar Y.B., Yi M., Kim W.Y., Shin J.G.,
RA   Lee S.J.;
RT   "Analysis of genetic polymorphism and biochemical characterization of
RT   a functionally decreased variant in prostacyclin synthase gene
RT   (CYP8A1) in humans.";
RL   Arch. Biochem. Biophys. 569C:10-18(2015).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 23-500 IN COMPLEX WITH HEME,
RP   AND COFACTOR.
RX   PubMed=17020766; DOI=10.1016/j.jmb.2006.09.039;
RA   Chiang C.W., Yeh H.C., Wang L.H., Chan N.L.;
RT   "Crystal structure of the human prostacyclin synthase.";
RL   J. Mol. Biol. 364:266-274(2006).
CC   -!- FUNCTION: Catalyzes the isomerization of prostaglandin H2 to
CC       prostacyclin (= prostaglandin I2).
CC   -!- CATALYTIC ACTIVITY: (5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-
CC       hydroxyprosta-5,13-dienoate = (5Z,13E)-(15S)-6,9-alpha-epoxy-11-
CC       alpha,15-dihydroxyprosta-5,13-dienoate.
CC       {ECO:0000269|PubMed:25623425}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:17020766};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9.55 uM for 6-keto-PGF1alpha {ECO:0000269|PubMed:25623425};
CC         Vmax=534 mmol/min/pg enzyme {ECO:0000269|PubMed:25623425};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein.
CC   -!- TISSUE SPECIFICITY: Widely expressed; particularly abundant in
CC       ovary, heart, skeletal muscle, lung and prostate.
CC   -!- DISEASE: Essential hypertension (EHT) [MIM:145500]: A condition in
CC       which blood pressure is consistently higher than normal with no
CC       identifiable cause. {ECO:0000269|PubMed:12372404}. Note=The
CC       disease may be caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP8A1 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp8a1.htm";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTGISID44219ch20q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D38145; BAA07343.1; -; mRNA.
DR   EMBL; AF297048; AAG31781.1; -; mRNA.
DR   EMBL; AF297049; AAG31782.1; -; mRNA.
DR   EMBL; AF297050; AAG31783.1; -; mRNA.
DR   EMBL; AF297051; AAG31784.1; -; mRNA.
DR   EMBL; AF297052; AAG31785.1; -; mRNA.
DR   EMBL; AL118525; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101809; AAI01810.1; -; mRNA.
DR   EMBL; BC101811; AAI01812.1; -; mRNA.
DR   CCDS; CCDS13419.1; -.
DR   PIR; JC2231; JC2231.
DR   RefSeq; NP_000952.1; NM_000961.3.
DR   UniGene; Hs.302085; -.
DR   PDB; 2IAG; X-ray; 2.15 A; A/B=23-500.
DR   PDB; 3B6H; X-ray; 1.62 A; A/B=18-500.
DR   PDBsum; 2IAG; -.
DR   PDBsum; 3B6H; -.
DR   ProteinModelPortal; Q16647; -.
DR   SMR; Q16647; -.
DR   BioGrid; 111712; 4.
DR   STRING; 9606.ENSP00000244043; -.
DR   BindingDB; Q16647; -.
DR   ChEMBL; CHEMBL4428; -.
DR   DrugBank; DB01240; Epoprostenol.
DR   DrugBank; DB00812; Phenylbutazone.
DR   GuidetoPHARMACOLOGY; 1356; -.
DR   SwissLipids; SLP:000001097; -.
DR   iPTMnet; Q16647; -.
DR   PhosphoSitePlus; Q16647; -.
DR   BioMuta; PTGIS; -.
DR   DMDM; 2493373; -.
DR   EPD; Q16647; -.
DR   MaxQB; Q16647; -.
DR   PaxDb; Q16647; -.
DR   PeptideAtlas; Q16647; -.
DR   PRIDE; Q16647; -.
DR   Ensembl; ENST00000244043; ENSP00000244043; ENSG00000124212.
DR   GeneID; 5740; -.
DR   KEGG; hsa:5740; -.
DR   UCSC; uc002xut.4; human.
DR   CTD; 5740; -.
DR   DisGeNET; 5740; -.
DR   GeneCards; PTGIS; -.
DR   HGNC; HGNC:9603; PTGIS.
DR   HPA; CAB009517; -.
DR   HPA; HPA014193; -.
DR   MalaCards; PTGIS; -.
DR   MIM; 145500; phenotype.
DR   MIM; 601699; gene.
DR   neXtProt; NX_Q16647; -.
DR   OpenTargets; ENSG00000124212; -.
DR   PharmGKB; PA292; -.
DR   eggNOG; KOG0684; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00550000074551; -.
DR   HOVERGEN; HBG051100; -.
DR   InParanoid; Q16647; -.
DR   KO; K01831; -.
DR   OMA; PRTHESQ; -.
DR   OrthoDB; EOG091G0767; -.
DR   PhylomeDB; Q16647; -.
DR   TreeFam; TF105090; -.
DR   BioCyc; MetaCyc:HS04738-MONOMER; -.
DR   BRENDA; 5.3.99.4; 2681.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   Reactome; R-HSA-197264; Nicotinamide salvaging.
DR   Reactome; R-HSA-211979; Eicosanoids.
DR   Reactome; R-HSA-211994; Sterols are 12-hydroxylated by CYP8B1.
DR   Reactome; R-HSA-2162123; Synthesis of Prostaglandins (PG) and Thromboxanes (TX).
DR   EvolutionaryTrace; Q16647; -.
DR   GeneWiki; Prostacyclin_synthase; -.
DR   GenomeRNAi; 5740; -.
DR   PRO; PR:Q16647; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124212; -.
DR   CleanEx; HS_PTGIS; -.
DR   Genevisible; Q16647; HS.
DR   GO; GO:0005901; C:caveola; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:InterPro.
DR   GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro.
DR   GO; GO:0008116; F:prostaglandin-I synthase activity; IDA:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB.
DR   GO; GO:0071354; P:cellular response to interleukin-6; IEP:UniProtKB.
DR   GO; GO:0019371; P:cyclooxygenase pathway; TAS:Reactome.
DR   GO; GO:0046697; P:decidualization; IEA:Ensembl.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0006690; P:icosanoid metabolic process; TAS:Reactome.
DR   GO; GO:0034356; P:NAD biosynthesis via nicotinamide riboside salvage pathway; TAS:Reactome.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:1900119; P:positive regulation of execution phase of apoptosis; IDA:UniProtKB.
DR   GO; GO:0035360; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR024204; Cyt_P450_CYP7A1-type.
DR   InterPro; IPR002403; Cyt_P450_E_grp-IV.
DR   InterPro; IPR027286; PTGIS.
DR   PANTHER; PTHR24306:SF9; PTHR24306:SF9; 1.
DR   Pfam; PF00067; p450; 1.
DR   PIRSF; PIRSF000047; Cytochrome_CYPVIIA1; 1.
DR   PIRSF; PIRSF500628; PTGIS; 1.
DR   PRINTS; PR00465; EP450IV.
DR   SUPFAM; SSF48264; SSF48264; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Endoplasmic reticulum;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Heme; Iron; Isomerase;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Metal-binding;
KW   Polymorphism; Prostaglandin biosynthesis; Prostaglandin metabolism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    500       Prostacyclin synthase.
FT                                /FTId=PRO_0000051910.
FT   TRANSMEM      1     20       Helical. {ECO:0000255}.
FT   METAL       441    441       Iron (heme axial ligand).
FT   VARIANT      38     38       P -> L (in allele CYP8A1*2).
FT                                {ECO:0000269|PubMed:11281454}.
FT                                /FTId=VAR_010915.
FT   VARIANT     118    118       S -> R (in allele CYP8A1*3;
FT                                dbSNP:rs5622).
FT                                {ECO:0000269|PubMed:11281454}.
FT                                /FTId=VAR_010916.
FT   VARIANT     154    154       E -> A (in dbSNP:rs5623).
FT                                /FTId=VAR_014634.
FT   VARIANT     171    171       F -> L (in dbSNP:rs5624).
FT                                /FTId=VAR_014635.
FT   VARIANT     236    236       R -> C (in dbSNP:rs5626).
FT                                /FTId=VAR_014636.
FT   VARIANT     379    379       R -> S (in allele CYP8A1*4;
FT                                dbSNP:rs56195291).
FT                                {ECO:0000269|PubMed:11281454}.
FT                                /FTId=VAR_010917.
FT   VARIANT     447    447       A -> T (in allele CYP8A1*5; results in a
FT                                significantly decreased enzyme activity;
FT                                dbSNP:rs146531327).
FT                                {ECO:0000269|PubMed:25623425}.
FT                                /FTId=VAR_073186.
FT   VARIANT     500    500       P -> S (in dbSNP:rs5584).
FT                                /FTId=VAR_014637.
FT   TURN         38     40       {ECO:0000244|PDB:3B6H}.
FT   HELIX        43     48       {ECO:0000244|PDB:3B6H}.
FT   HELIX        50     61       {ECO:0000244|PDB:3B6H}.
FT   STRAND       63     69       {ECO:0000244|PDB:3B6H}.
FT   STRAND       72     77       {ECO:0000244|PDB:3B6H}.
FT   HELIX        80     82       {ECO:0000244|PDB:3B6H}.
FT   HELIX        83     87       {ECO:0000244|PDB:3B6H}.
FT   TURN         91     93       {ECO:0000244|PDB:3B6H}.
FT   STRAND       94     96       {ECO:0000244|PDB:2IAG}.
FT   HELIX        98    106       {ECO:0000244|PDB:3B6H}.
FT   HELIX       117    125       {ECO:0000244|PDB:3B6H}.
FT   HELIX       130    155       {ECO:0000244|PDB:3B6H}.
FT   STRAND      160    163       {ECO:0000244|PDB:3B6H}.
FT   HELIX       164    181       {ECO:0000244|PDB:3B6H}.
FT   HELIX       190    219       {ECO:0000244|PDB:3B6H}.
FT   HELIX       224    240       {ECO:0000244|PDB:3B6H}.
FT   HELIX       243    246       {ECO:0000244|PDB:3B6H}.
FT   HELIX       254    265       {ECO:0000244|PDB:3B6H}.
FT   HELIX       270    285       {ECO:0000244|PDB:3B6H}.
FT   HELIX       288    300       {ECO:0000244|PDB:3B6H}.
FT   HELIX       303    318       {ECO:0000244|PDB:3B6H}.
FT   HELIX       333    336       {ECO:0000244|PDB:3B6H}.
FT   HELIX       339    352       {ECO:0000244|PDB:3B6H}.
FT   STRAND      357    361       {ECO:0000244|PDB:3B6H}.
FT   STRAND      365    368       {ECO:0000244|PDB:3B6H}.
FT   STRAND      374    377       {ECO:0000244|PDB:3B6H}.
FT   STRAND      382    385       {ECO:0000244|PDB:3B6H}.
FT   HELIX       388    392       {ECO:0000244|PDB:3B6H}.
FT   TURN        395    397       {ECO:0000244|PDB:3B6H}.
FT   STRAND      398    400       {ECO:0000244|PDB:3B6H}.
FT   TURN        406    409       {ECO:0000244|PDB:3B6H}.
FT   STRAND      414    416       {ECO:0000244|PDB:3B6H}.
FT   HELIX       444    460       {ECO:0000244|PDB:3B6H}.
FT   STRAND      462    468       {ECO:0000244|PDB:3B6H}.
FT   HELIX       478    480       {ECO:0000244|PDB:3B6H}.
FT   STRAND      482    485       {ECO:0000244|PDB:3B6H}.
FT   STRAND      488    490       {ECO:0000244|PDB:3B6H}.
FT   STRAND      493    498       {ECO:0000244|PDB:3B6H}.
SQ   SEQUENCE   500 AA;  57104 MW;  39595442BFC0B625 CRC64;
     MAWAALLGLL AALLLLLLLS RRRTRRPGEP PLDLGSIPWL GYALDFGKDA ASFLTRMKEK
     HGDIFTILVG GRYVTVLLDP HSYDAVVWEP RTRLDFHAYA IFLMERIFDV QLPHYSPSDE
     KARMKLTLLH RELQALTEAM YTNLHAVLLG DATEAGSGWH EMGLLDFSYS FLLRAGYLTL
     YGIEALPRTH ESQAQDRVHS ADVFHTFRQL DRLLPKLARG SLSVGDKDHM CSVKSRLWKL
     LSPARLARRA HRSKWLESYL LHLEEMGVSE EMQARALVLQ LWATQGNMGP AAFWLLLFLL
     KNPEALAAVR GELESILWQA EQPVSQTTTL PQKVLDSTPV LDSVLSESLR LTAAPFITRE
     VVVDLAMPMA DGREFNLRRG DRLLLFPFLS PQRDPEIYTD PEVFKYNRFL NPDGSEKKDF
     YKDGKRLKNY NMPWGAGHNH CLGRSYAVNS IKQFVFLVLV HLDLELINAD VEIPEFDLSR
     YGFGLMQPEH DVPVRYRIRP
//
